Kang, H.-J. Kim, G.-C. Lee, C.-G. Park, S. Sharma, G. Verma, R. Im, S.-H. Kwon, H.-K. 2024-01-19T15:03:36Z 2024-01-19T15:03:36Z 2021-09-02 2021-04 0091-6749 https://pubs.kist.re.kr/handle/201004/117233 [No abstract available] English Mosby Inc. Probiotics-derived metabolite ameliorates skin allergy by promoting differentiation of FOXP3+ regulatory T cells Article 10.1016/j.jaci.2020.11.040 1 Journal of Allergy and Clinical Immunology, v.147, no.4, pp.1517 - 1521 Journal of Allergy and Clinical Immunology 147 4 1517 1521 N scie scopus 001162865700001 2-s2.0-85099048988 Allergy Immunology Allergy Immunology Letter probiotic agent transcription factor FOXP3 Article drug effect drug efficacy drug mechanism human immunomodulation nonhuman priority journal regulatory T lymphocyte skin allergy contact hypersensitivity Foxp3 Regulatory T cells probiotics metabolite propionate skin allergy atopic dermatitis